{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:37:29Z","timestamp":1794649049484,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Filaria J"],"DOI":"10.1186\/1475-2883-2-s1-s5","type":"journal-article","created":{"date-parts":[[2003,10,26]],"date-time":"2003-10-26T00:18:04Z","timestamp":1067127484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Possible pathogenic pathways in the adverse clinical events seen following ivermectin administration to onchocerciasis patients."],"prefix":"10.1186","volume":"2","author":[{"given":"Charles D","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,24]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/jac\/34.2.195","volume":"34","author":"EA Ottesen","year":"1994","unstructured":"Ottesen EA, Campbell WC: Review. Ivermectin in human medicine. J Antimicrobial Chemotherapy. 1994, 34: 195-203.","journal-title":"J Antimicrobial Chemotherapy"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2165\/00003495-199142040-00007","volume":"42","author":"KL Goa","year":"1991","unstructured":"Goa KL, McTavish D, Clissold SP: Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs. 1991, 42: 640-658.","journal-title":"Drugs"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1079\/9780851996172.0405","volume-title":"In: Macrocyclic lactones in antiparasitic therapy","author":"KR Brown","year":"2002","unstructured":"Brown KR: The use of macrocyclic lactones to control parasites in humans. In: Macrocyclic lactones in antiparasitic therapy. Edited by: Vercruysse J, Rew RS. 2002, Oxon, CABI Publishing, 405-412."},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev.mi.45.100191.002305","volume":"45","author":"WC Campbell","year":"1991","unstructured":"Campbell WC: Ivermectin as an antiparasitic agent for use in humans. Ann Rev Microbiol. 1991, 45: 445-74. 10.1146\/annurev.mi.45.100191.002305.","journal-title":"Ann Rev Microbiol"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0140-6736(96)11094-1","volume":"350","author":"J Gardon","year":"1997","unstructured":"Gardon J, Gardon-Wendel N, Demanga-Ngangue , Kamgno J, Chippaux JP, Boussinesq M.: Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet. 1997, 350: 18-22. 10.1016\/S0140-6736(96)11094-1.","journal-title":"Lancet"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/0169-4758(96)40006-0","volume":"11","author":"JP Chippaux","year":"1996","unstructured":"Chippaux JP, Bousinessq M, Gardon J, Gardon-Wendel N, Emould JC: Severe adverse reaction risks during mass treatment with ivermectin in loiasis endemic areas. Parasit Today. 1996, 11: 448-50. 10.1016\/0169-4758(96)40006-0.","journal-title":"Parasit Today"},{"key":"22_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.4269\/ajtmh.1998.58.461","volume":"58","author":"M Boussinesq","year":"1998","unstructured":"Boussinesq M, Gardon J, Gardon-Wendel N, Kamdno J, Ngoumou P, Chippaux JP: Three probable cases of Loa loa encephalopathy following ivermectin treatment in onchocerciasis. Am J Trop Med Hyg. 1998, 58: 461-9.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/clinids\/7.6.802","volume":"7","author":"CD Mackenzie","year":"1985","unstructured":"Mackenzie CD, Williams JF, Sisley BM, Steward MW, O'Day J: Variations in host immune response in relation to immunopathology in human onchocerciasis. Rev Infect Dis. 1985, 7: 802-808.","journal-title":"Rev Infect Dis"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1086\/367709","volume":"187","author":"MM Ali","year":"2003","unstructured":"Ali MM, Muhktar M, Baraka OZ, Suliaman S, Williams JF, Homeida MA, Mackenzie CD: Immune responses directed against microfilariae correlate with the severity of clinical onchodermatitis and treatment history. J Inf Dis. 2003, 187: 714-717. 10.1086\/367709.","journal-title":"J Inf Dis"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/0035-9203(95)90559-6","volume":"89","author":"OZ Baraka","year":"1995","unstructured":"Baraka OZ, Mahmoud BM, Ali MM, Ali MH, ElSheikh EA, Homeida MM, Mackenzie CD, Williams JF: Ivermectin treatment in severe a symmetric reactive onchodermatitis (sowda) in Sudan. Trans R Soc Trop Med Hyg. 1995, 89: 312-5.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0001-706X(02)00117-1","volume":"84","author":"MM Ali","year":"2002","unstructured":"Ali MM, Mukhtar MM, Baraka OZ, Homeida MM, Kheir MM, Mackenzie CD: Immunocompetence may be important in the effectiveness of Mectizan\u00ae ivermectin in the treatment of human onchocerciasis. Acta Tropica. 2002, 84: 49-53. 10.1016\/S0001-706X(02)00117-1.","journal-title":"Acta Tropica"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2249.1994.tb06548.x","volume":"96","author":"PT Soboslay","year":"1994","unstructured":"Soboslay PT, Luder CG, Hoffman WH, Michael I, Helling G, Heuschkel C, Dreweck CM, Blanke CH, Pritze S, Banla M: Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection. Clin exp Immunol. 1994, 96: 238-44.","journal-title":"Clin exp Immunol"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0169-4758(92)90003-K","volume":"8","author":"H Schultz-Key","year":"1992","unstructured":"Schultz-Key H, Soboslay PT, Hoffman WH: Ivermectin-facilitated immunity. Parasit Today. 1992, 8: 152-3. 10.1016\/0169-4758(92)90003-K.","journal-title":"Parasit Today"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00001432-200112000-00011","volume":"14","author":"MJ Taylor","year":"2001","unstructured":"Taylor MJ, Hoerauf A: A new approach to the treatment of filariasis. Curr Opin Inf Dis. 2001, 14: 727-31.","journal-title":"Curr Opin Inf Dis"},{"key":"22_CR15","first-page":"R1","volume":"82","author":"CD Mackenzie","year":"1985","unstructured":"Mackenzie CD, Kron MA: Diethylcarbamazine: a review of its action in onchocerciasis, lymphatic filariasis and inflammation. Trop Dis Bull. 1985, 82: R1-R37.","journal-title":"Trop Dis Bull"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/00034980120073184","volume":"95","author":"M Boussinesq","year":"2001","unstructured":"Boussinesq M, Gardon J, Kamgno J, Pion SDS, Gardon-Wendel N, Chippaux JP: Relationships between the prevelance and intensity of Loa Loa infection in the Central Province of Cameroon. Ann Trop Med Parasit. 2001, 95: 495-507. 10.1080\/00034980120073184.","journal-title":"Ann Trop Med Parasit"},{"key":"22_CR17","unstructured":"Addiss D: Minutes of the MDP Sponsored Meeting on \"Central Nervous Disorders following treatment with Mectizan\u00ae in areas co-endemic for onchocerciasis and loiasis\". University of Tours, Tours, France. 7\u20138 October, 1999"},{"key":"22_CR18","first-page":"105","volume":"88","author":"M Ducorps","year":"1995","unstructured":"Ducorps M, Gardon-Wendel N, Ranque S, Ndong W, Boussinesq M, Gardon J, Schneider D, Chippaux J-P: Effets secondaires du traitment de la loase hypermicrofilaemique par l'ivermectine. Bull Soc Path Ex. 1995, 88: 105-112.","journal-title":"Bull Soc Path Ex"},{"key":"22_CR19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.4269\/ajtmh.1991.44.684","volume":"44","author":"B Carme","year":"1991","unstructured":"Carme B, Boulesteix J, Boutes H, Pruehence MF: Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg. 1991, 44: 684-690.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jramc-112-01-09","volume":"112","author":"CGB Downie","year":"1996","unstructured":"Downie CGB: Encephalitis during treatment of loiasis with diethylcarbamazine. J Royal Army Med Corps. 1996, 112: 46-49.","journal-title":"J Royal Army Med Corps"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/archopht.1965.00970040472007","volume":"74","author":"D Toussaint","year":"1965","unstructured":"Toussaint D, Danis P: Retinopathy in generalized Loa-loa filariasis. A clinico-pathological study. Arch Ophthalmol. 1965, 74: 470-476.","journal-title":"Arch Ophthalmol"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1076\/0928-6586(200003)711-2FT027","volume":"7","author":"G Fobi","year":"2000","unstructured":"Fobi G, Gardon J, Santiago M, Ngangue D, Gardon-Wendel N, Boussinesq M: Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiology. 2000, 7: 27-39. 10.1076\/0928-6586(200003)7:1;1-2;FT027.","journal-title":"Ophthalmic Epidemiology"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4269\/ajtmh.1988.39.480","volume":"39","author":"D Richard-Lenoble","year":"1988","unstructured":"Richard-Lenoble D, Kombila M, Rupp EA, Pappaliou ES, Gaxotte P, Nguiri C, Aziz MA: Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg. 1988, 39: 480-483.","journal-title":"Am J Trop Med Hyg"},{"key":"22_CR24","first-page":"381","volume":"107","author":"M Langlois","year":"1962","unstructured":"Langlois M, Perrouty P, Daoulas R, Bertton M: Filarose loa, thrombose de l'artere centrale de la retine et syndrome cerebelleux. Rev Neurol. 1962, 107: 381-5.","journal-title":"Rev Neurol"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jnnp.18.2.103","volume":"18","author":"L van Bogaert","year":"1955","unstructured":"van Bogaert L, Dubois A, Janssens PG, Rademecker J, Tverdy G, Wanson M: Encephalitis in Loa-Loa Filariasis. J Neurol Neurosurg Psychiat. 1955, 18: 103-119.","journal-title":"J Neurol Neurosurg Psychiat"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0001-706X(00)00159-5","volume":"78","author":"M Blum","year":"2001","unstructured":"Blum M, Wiestner A, Fuhr P, Hatz C: Encephalopathy following Loa loa treatment with albendazole. Acta Trop. 2001, 78: 63-65. 10.1016\/S0001-706X(00)00159-5.","journal-title":"Acta Trop"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1365-2885.1987.tb00083.x","volume":"10","author":"AWJ Tranquilli","year":"1987","unstructured":"Tranquilli AWJ, Paul AJ, Seward RL, Todd KS, Dipietro JA: Response to physostigmine administration in collie dogs exhibiting ivermectin toxicosis. J vet Pharmacol Therapeut. 1987, 10: 96-100.","journal-title":"J vet Pharmacol Therapeut"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"13949","DOI":"10.1073\/pnas.240464697","volume":"97","author":"NS Kane","year":"2000","unstructured":"Kane NS, Hirschberg B, Qian S, Hunt D, Thomas B, Brochu R, Lumerer SW, Zheng Y, Smith M, Arena JP, Cohen CJ, Schmatz D, Warmke J, Cully DF: Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin. PNAS. 2000, 97: 13949-13954. 10.1073\/pnas.240464697.","journal-title":"PNAS"},{"key":"22_CR29","first-page":"1051","volume":"295","author":"GR Dawson","year":"2000","unstructured":"Dawson GR, Wafford KA, Smith A, Marchall GR, Bayley PJ, Schaeffer JM, Meinke PT, Mckernan RM: Anticonvuslant and adverse effects of avermectin analogs in mice are mediated through the y-aminobutyric acidA receptor. J Pharm Exp Therapeut. 2000, 295: 1051-1060.","journal-title":"J Pharm Exp Therapeut"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1074\/jbc.M011264200","volume":"276","author":"Q Shan","year":"2001","unstructured":"Shan Q, Haddrill JL, Lynch JW: Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J Biol Chem. 2001, 276: 12556-12564. 10.1074\/jbc.M011264200.","journal-title":"J Biol Chem"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0166-6851(01)00258-4","volume":"114","author":"CL Cheeseman","year":"2001","unstructured":"Cheeseman CL, Delany NS, Woods DJ, Wolstenholme AJ: High-affinity ivermectin binding to recombinant subunits of the Haemonchus contortus glutamate-gated chloride channel. Mol Biochem Parasit. 2001, 114: 161-168. 10.1016\/S0166-6851(01)00258-4.","journal-title":"Mol Biochem Parasit"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1021\/js9701364","volume":"86","author":"J van Asperen","year":"1997","unstructured":"van Asperen J, Mayer U, van Tellingen O, Beijnen JH: The functional role of P-glycoprotein in the blood-brain barrier. J Pharm Sci. 1997, 86: 881-884. 10.1021\/js9701364.","journal-title":"J Pharm Sci"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1172\/JCI118699","volume":"97","author":"AH Schinkel","year":"1992","unstructured":"Schinkel AH, Wagenaar E, Mol CA, van Deemter L: P-glycoprotein in the blood-brain barrier of mice influence the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1992, 97: 2517-2524.","journal-title":"J Clin Invest"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0092-8674(94)90212-7","volume":"77","author":"AH Schinkel","year":"1994","unstructured":"Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L: Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994, 77: 491-502.","journal-title":"Cell"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1939-1676.2002.tb01611.x","volume":"16","author":"K Hopper","year":"2002","unstructured":"Hopper K, Aldrich J, Haskins SC: Ivermectin toxicity in 17 collies. J Vet Int Med. 2002, 16: 89-94.","journal-title":"J Vet Int Med"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2460\/ajvr.2002.63.479","volume":"63","author":"Kl Mealey","year":"2002","unstructured":"Mealey Kl, Bentjen SA, Waiting DK: Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of collies from the northwestern United States. Am J Vet Res. 2002, 63: 479-481.","journal-title":"Am J Vet Res"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/00008571-200111000-00012","volume":"11","author":"KL Mealey","year":"2001","unstructured":"Mealey KL, Bentjen SA, Gay JM, Cantor GH: Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics. 2001, 11: 727-733. 10.1097\/00008571-200111000-00012.","journal-title":"Pharmacogenetics"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1046\/j.1365-3156.1999.00442.x","volume":"4","author":"A Garcia","year":"1999","unstructured":"Garcia A, Abel L, Cot M, Richard P, Ranque S, Feingold J, Demenais F, Boussinesq M, Chippaux J-P: Genetic epidemiology of host predisposition microfilaremia in human loiasis. Trop Med Int Health. 1999, 4: 565-574. 10.1046\/j.1365-3156.1999.00442.x.","journal-title":"Trop Med Int Health"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1365-3024.1996.tb01032.x","volume":"18","author":"S Winkler","year":"1996","unstructured":"Winkler S, Paiha S, Winkler H, Graninger W, Marberger M, Steiner GE: Microfilarial clearance in loiasis involves elevation of Th1 and Th2 products and emergence of a specific pattern of T-cell populations. Para Immunol. 1996, 18: 479-482.","journal-title":"Para Immunol"}],"container-title":["Filaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2883-2-S1-S5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:24:31Z","timestamp":1726241071000},"score":1,"resource":{"primary":{"URL":"https:\/\/filariajournal.biomedcentral.com\/articles\/10.1186\/1475-2883-2-S1-S5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,24]]},"references-count":39,"journal-issue":{"issue":"S1","published-online":{"date-parts":[[2003,10]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1186\/1475-2883-2-s1-s5","relation":{},"ISSN":["1475-2883"],"issn-type":[{"value":"1475-2883","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,24]]},"assertion":[{"value":"24 October 2003","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S5"}}